From Yahoo Finance: 2025-03-31 09:33:00

Jim Cramer recently reviewed 23 stocks, including Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Cramer expressed optimism in the market, noting gains across diverse sectors. He highlighted the shift away from tech stocks and the surprising success of other sectors. Despite concerns of a recession, Cramer found the market to be healthier than expected. Vertex Pharmaceuticals, known for cystic fibrosis treatments, reported a 12% revenue increase in 2024, driven by strong performance. While Vertex ranks 3rd on Cramer’s list, AI stocks may offer greater promise for higher returns. Hedge fund sentiment and stock analysis were provided for each stock mentioned.



Read more at Yahoo Finance: “Revolutionary Pain Drug on the Horizon!”